Expression of P-glycoprotein, encoded by MDR 1 gene, a metabolically active efflux pump in murine mast cells

D Wein1, S Gupta

  • 1Division of Basic and Clinical Immunology, Medical Sciences I, University of California, Irvine 92717, USA.

Cancer Letters
|March 29, 1996
PubMed

Insights

Mast cells express functional P-glycoprotein (P-gp), a transporter protein. This finding suggests P-gp may play a role in mast cell mediator secretion.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Mast cells are key immune cells involved in allergic responses and inflammation.
  • P-glycoprotein (P-gp) is a well-known efflux transporter implicated in multidrug resistance.

Purpose of the Study:

  • To investigate the expression and function of P-glycoprotein (P-gp) in a murine mast cell line (MC/9).
  • To determine if P-gp in mast cells is functionally active and capable of transporting substrates.

Main Methods:

  • P-gp expression was assessed at both protein (flow cytometry, Western blot) and mRNA (RT-PCR) levels.
  • Rhodamine 123 (Rh123) accumulation and efflux assays were performed in the presence and absence of cyclosporin A (CSA) and its analog (CSA-1).

Main Results:

  • P-glycoprotein (P-gp) was detected in mast cells at both protein and mRNA levels.
  • Cyclosporin A (CSA) and CSA-1 significantly increased intracellular accumulation of Rh123 and inhibited its efflux, indicating P-gp activity.
  • These results confirm the presence of a functionally active P-gp in mast cells.

Conclusions:

  • Mast cells express functionally active P-glycoprotein (P-gp).
  • The study suggests a potential physiological role for P-gp in the secretion of mediators and cytokines from mast cells.
  • This highlights P-gp as a potential target for modulating mast cell function.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...